Method for treating cognitive disorders with phenserine

US5409948A · kind A · utility

Assignee

• The United States of America as Represented by the Secretary of the Department of Health and Human Services · US

Inventors

• Nigel H. Greig · Phoenix, US
• Arnold Brossi · Bethesda, US
• Timothy T. Soncrant · Silver Spring, US
• Harold W. Holloway · Middle River, US
• Stanley I. Rapoport · Washington, US
• Setsu Iijima · Tokyo, JP
• Edward L. Spangler · Baltimore, US
• Donald K. Ingram · Ellicott City, US
• Xue-Feng Pei · Washington, US

Key dates

• Filing date: Nov 23, 1992
• Grant date: Apr 25, 1995
• Expiry date: Nov 23, 2012

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An improved method of cholinomimetic therapy for cognitive impairments associated with aging and Alzheimer's disease comprising treating a patient with an effective amount of phenserine or a pharmaceutically acceptable salt and derivatives.